BridgeMD
New treatment option for Transcutaneous Tibial Nerve Stimulation
Official title Transcutaneous Tibial Nerve Stimulation on Women With Primary Dysmenorrhea
ClinicalTrials.gov ID: NCT07352982
What this study is testing
What is Traditional treatment (Nonsteroidal anti-inflammatory drugs)?
Traditional treatment (Nonsteroidal anti-inflammatory drugs) is an investigational medicine, being studied as a potential treatment for transcutaneous tibial nerve stimulation.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to investigate the effects of transcutaneous tibial nerve stimulation (TTNS) on women with primary dysmenorrhea (PD).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 25, women only
You may be able to join if
- Age ranges from 20-25 years old.
- Body mass index (BMI) doesn't exceed 30 kg/m2.
- Patients referred from a Gynecologist with a diagnosis of Primary Dysmenorrhea (PD).
- Patients have regular menstrual cycles.
- Patients suffer from pain located in the suprapubic area, abdomen, lower lumbar area, perineum, and/or medial aspect of the thighs during at least...
You likely can't join if
- Patients diagnosed with gynecological pathology.
- Patients taking oral contraceptives or had an intrauterine device implanted.
- Patients had bad obstetric situations or diseases that could interfere with participation.
- Patients have certain disorders including uncorrected coagulopathies, severe comorbid disorder, cancer in the last 5 years or at present, presence of...
- Patients who are smoking or taking oral sedatives.
- Patients had undergone surgery or childbirth in the last 6 months.
See the full eligibility criteria
- Age ranges from 20-25 years old.
- Body mass index (BMI) doesn't exceed 30 kg/m2.
- Patients referred from a Gynecologist with a diagnosis of Primary Dysmenorrhea (PD).
- Patients have regular menstrual cycles.
- Patients suffer from pain located in the suprapubic area, abdomen, lower lumbar area, perineum, and/or medial aspect of the thighs during at least half of their annual menstrual cycles and/or in the last 3 cycles.
- Patients diagnosed with gynecological pathology.
- Patients taking oral contraceptives or had an intrauterine device implanted.
- Patients had bad obstetric situations or diseases that could interfere with participation.
- Patients have certain disorders including uncorrected coagulopathies, severe comorbid disorder, cancer in the last 5 years or at present, presence of erosions on the inner aspect of the ankle, severe mental disorders...
- Patients who are smoking or taking oral sedatives.
- Patients had undergone surgery or childbirth in the last 6 months.
- Patients who are pregnant.
The study team makes the final eligibility decision.
Where it's taking place
- Kafr ash Shaykh, Kafrelsheikh, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 20 years to 25 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kafr ash Shaykh, Kafrelsheikh, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.